Skip to main content
Article
Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
Proceedings of the National Academy of Sciences of the United States of America (2010)
  • Xiaolong Wei, Harvard University
  • David Dombkowski, Harvard University
  • Katia Meirelles, Harvard University
  • Rafael Pieretti-Vanmarcke, Harvard University
  • Paul P. Szotek, Harvard University
  • Henry L. Chang, Harvard University
  • Frederic I. Preffer, Harvard University
  • Peter R. Mueller, Harvard University
  • Jose Teixeira, Harvard University
  • David T. MacLaughlin, Harvard University
  • Patricia K. Donahoe, Harvard University
Publication Date
November 2, 2010
DOI
10.1073/PNAS.1012667107
Citation Information
Xiaolong Wei, David Dombkowski, Katia Meirelles, Rafael Pieretti-Vanmarcke, et al.. "Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics" Proceedings of the National Academy of Sciences of the United States of America Vol. 107 Iss. 44 (2010) p. 18874 - 18879
Available at: http://works.bepress.com/henry-chang/4/